Form 4: Fulgent Genetics President and COO Jian Xie Reports Tax Withholding Stock Transaction

Jian Xie, President and COO of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On October 26, 2024, Jian Xie, the President and COO of Fulgent Genetics, had 4,345 shares of common stock withheld at a price of $19.42 per share to cover tax obligations.
• This withholding was related to the vesting of restricted stock units granted on November 7, 2022.
• Following the transaction, Mr. Xie directly owns 336,825 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.
• Mr. Xie serves on the investment committee of the Trust and disclaims beneficial interest except for any pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, indicating a neutral sentiment.

Management Comments

• Mr. Xie disclaims any beneficial interest in the shares held by The Hsieh Family Dynasty Trust except with respect to any pecuniary interest therein.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock, which is a common practice across publicly traded companies.

Key Dates